The "Ping An Circle" has signed a deep cooperation agreement with YIXINTANG, JZJ, and Guizhou Yishu, three major regional chains36Kr·Mar 15 at 10:46 PM01833+0.26%510660+0.61%
CITIC Construction Investment: The pharmacy industry is currently recovering moderately, and transformation is expected to catalyze valuation enhancementZhitong·Sep 10, 2025 at 01:16 AM605266-0.66%002727-1.20%
JZJ: The shareholding ratio of the actual controller and controlling shareholder has increased to 40.7056%Zhitong·Jul 1, 2025 at 03:13 AM605266-0.66%
China Post Securities: The retail pharmacy industry continues to clear out, and the ongoing coordination is expected to bring performance growthZhitong·Jul 1, 2025 at 01:57 AM603233-1.10%605266-0.66%
Pharmaceutical commercial stocks opened strong, with YIXINTANG hitting the limit up, Hezong Medicine Easy-To-Buy Pharmaceutical rising over 10%, and JZJ, Saili Medical, Huaren Health, SYPM, and others following suitWallstreetcn·May 20, 2025 at 08:32 PM300937+2.89%605266-0.66%
Zhitong A-share lock-up release overview | April 29Zhitong·Apr 28, 2025 at 08:01 PM603299-0.21%603456+1.46%
JZJ: Net profit in the first quarter of 2025 decreased by 35.85% year-on-yearZhitong·Apr 28, 2025 at 09:29 AM605266-0.66%
Closing Review: Three major stock indices slightly declined, and the pharmaceutical commercial concept remained activeZhitong·Mar 10, 2025 at 02:02 AM605266-0.66%603716+2.21%
The pharmaceutical commercial sector is active against the trend, LBX hits the daily limit in the afternoonZhitong·Mar 10, 2025 at 12:34 AM301017+8.37%603939-0.31%
JZJ spent CNY 94.9581 million to complete the repurchase of 2.77% of its sharesZhitong·Feb 5, 2025 at 03:05 AM605266-0.66%
JZJ: Net profit is expected to decrease by 68.78% to 65.50% in 2024Zhitong·Jan 17, 2025 at 05:25 AM605266-0.66%
The pharmaceutical commercial concept fluctuates downward, HRPC approaches the limit downZhitong·Jan 6, 2025 at 11:09 PM300937+2.89%605266-0.66%
